Authorised Phase III and phase IV (Integrated) post-acute sequelae of COVID-19

[68Ga]FAPI PET/CT to detect fibroblast activity in pulmonary COVID patients with and without long-term health problems.

Q: Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Q: Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

Q: How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Q: Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

EU CTIS ID: 2024-517931-29-00

What this study is testing

To assess if pulmonary fibroblast activity, measured by [68Ga]FAPI-PET/CT, is higher in patients with current long COVID dyspnea and fatigue compared to patients with resolved complaints.

Phase III and phase IV (Integrated)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

Adult patients > 20 years
Self-reported complaints of dyspnea or fatigue > 3 months after SARS-CoV-2 infection confirmed with PCR, serology test or COVID-19 Reporting and Data System (CO-RADS) score 4/5.
Group 1: Fatigue Severity Scale ≥ 4 at time of [68Ga]FAPI PET/CT
Group 2: Fatigue Severity Scale < 4 at time of [68Ga]FAPI PET/CT after having previously recorded score of ≥ 4 or equivalent.
In addition, when insufficient when insufficient subjects can be included in group 2 ‘Healthy’ controls will be included from the Lifelines or PARASOL cohort with the following criteria: Patients without self-reported complaints and past SARS-CoV-2 infection (which would have resulted in a Fatigue Severity Scale < 4) or without experienced confirmed SARS-CoV-2 infection.

You likely can't join if

Inability or unwilling to give informed consent.
History of claustrophobia or feeling of inability to tolerate supine position for the PET/CT scans.

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH)Heart failure Coronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.